InflaRx N.V. Return on Equity

InflaRx N.V. (IFRX) currently reports a ROE of -25.62%. That is above the Healthcare sector average of -100.59%. Use the charts on this page to explore InflaRx N.V.'s ROE history and peer comparisons.

InflaRx N.V.'s ROE of -25.62% is higher than the Healthcare sector average of -100.59%. That is roughly 74.5% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but InflaRx N.V.'s current -25.62% should be judged against Healthcare norms (sector average: -100.59%) and against IFRX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -25.62%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is -100.59%. From there, open related valuation or income-statement pages for InflaRx N.V., and consider following IFRX for alerts when major investors trade the stock.

InflaRx N.V. is classified in the Healthcare sector. On ROE, it currently shows -25.62% versus a sector average near -100.59%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IFRX with unrelated industries.